Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens

European Journal of Cancer

Volumn 49, Issue 1, 2013, Pages 132-141

  Reitsma, Welmoed ^a   De Bock, Geertruida H ^b   Oosterwijk, Jan C ^b   Bart, Joost ^b   Hollema, Harry ^b   Mourits, Marian J E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

BRCA; Occult carcinoma; Risk reducing salpingo oophorectomy; Serous tubal intraepithelial carcinoma

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PERITONEUM CANCER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN LOCALIZATION; RISK ASSESSMENT; RISK REDUCING SALPINGOOOPHORECTOMY; RISK REDUCTION; SALPINGOOOPHORECTOMY; UTERINE TUBE;

ADULT; AGED; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASMS, UNKNOWN PRIMARY; OVARIAN NEOPLASMS; OVARIECTOMY; PREVALENCE; RISK FACTORS;

EID: 84871408680     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.07.021     Document Type: Article

References (40)

1. W.H. Gotlieb, G.B. Baruch, and E. Friedman Prophylactic oophorectomy: clinical considerations Semin Surg Oncol 19 2000 20 27 (Pubitemid 30439311)
2. E.B. Claus, J.M. Schildkraut, W.D. Thompson, and N.J. Risch The genetic attributable risk of breast and ovarian cancer Cancer 77 1996 2318 2324 (Pubitemid 26162426)
3. H.T. Lynch, M.J. Casey, T.G. Shaw, and J.F. Lynch Hereditary factors in gynecologic cancer Oncologist 3 1998 319 338 (Pubitemid 28485574)
4. A. Antoniou, P.D. Pharoah, and S. Narod Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 2003 1117 1130 (Pubitemid 36530000)
5. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 2007 1329 1333 (Pubitemid 46706879)
6. B.B. Hermsen, R.I. Olivier, and R.H. Verheijen No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study Br J Cancer 96 2007 1335 1342 (Pubitemid 46685786)
7. N.M. van der Velde, M.J. Mourits, and H.J. Arts Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer 124 2009 919 923
8. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2009 80 87
9. A. Finch, M. Beiner, and J. Lubinski Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation JAMA 296 2006 185 192
10. J.D. Seidman, P. Zhao, and A. Yemelyanova "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer Gynecol Oncol 120 2011 470 473
11. K. Leeper, R. Garcia, and E. Swisher Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol Oncol 87 2002 52 56 (Pubitemid 36027101)
12. D.G. Evans, R. Clayton, P. Donnai, A. Shenton, and F. Lalloo Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk Eur J Hum Genet 17 2009 1381 1385
13. M.J. Callahan, C.P. Crum, and F. Medeiros Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 2007 3985 3990 (Pubitemid 47477278)
14. Reitsma W, Hollema H, Mourits MJ. Letter commenting on "risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol" in Int J Gynecol Cancer 2011;21:846-851 by C. Bethan Powell et al. Int J Gynecol Cancer 2012;22:2. Available from: < http://www.ncbi.nlm.nih.gov/pubmed/21892089 >.
15. C.P. Crum, R. Drapkin, and D. Kindelberger Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer Clin Med Res 5 2007 35 44 (Pubitemid 350218778)
16. J. Kim, D.M. Coffey, and C.J. Creighton High-grade serous ovarian cancer arises from fallopian tube in a mouse model Proc Natl Acad Sci U S A 109 2012 3921 3926
17. M.J. Mourits, and G.H. de Bock Managing hereditary ovarian cancer Maturitas 64 2009 172 176
18. Available from: < http://www.stoet.nl/uploads/richtlijnenboekje.pdf > (viewed on November 1st, 2011).
19. I.E. Fakkert, L. Jansen, and K. Meijer Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy Breast Cancer Res Treat 129 2011 157 164
20. I. Yanai-Inbar, S. Siriaunkgul, and S.G. Silverberg Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential? Int J Gynecol Pathol 14 1995 107 113
21. M.J. Kenkhuis, G.H. de Bock, and P.O. Elferink Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers Maturitas 66 2010 310 314
22. F. Medeiros, M.G. Muto, and Y. Lee The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236 (Pubitemid 43740193)
23. M.H. Roh, D. Kindelberger, and C.P. Crum Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 33 2009 376 383
24. T.R. Rebbeck, H.T. Lynch, and S.L. Neuhausen Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622 (Pubitemid 34755669)
25. S.M. Domchek, T.M. Friebel, and J.E. Garber Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers Breast Cancer Res Treat 124 2010 195 203
26. C.B. Powell, E. Kenley, and L.M. Chen Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132 (Pubitemid 41702631)
27. J.T. Rabban, M. Barnes, and L.M. Chen Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma Am J Surg Pathol 33 2009 1125 1136
28. J.E. Hirst, G.B. Gard, K. McIllroy, D. Nevell, and M. Field High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy Int J Gynecol Cancer 19 2009 826 829
29. M.S. Yates, L.A. Meyer, and M.T. Deavers Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis Cancer Prev Res (Phila) 4 2011 463 470
30. M.L. Carcangiu, B. Peissel, and B. Pasini Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature Am J Surg Pathol 30 2006 1222 1230 (Pubitemid 44454699)
31. C.B. Powell, L.M. Chen, and J. McLennan Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol Int J Gynecol Cancer 21 2011 846 851
32. R. Manchanda, A. Abdelraheim, and M. Johnson Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status BJOG 118 2011 814 824
33. P.A. Meeuwissen, C. Seynaeve, and C.T. Brekelmans Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer Gynecol Oncol 97 2005 476 482 (Pubitemid 40614892)
34. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 2001 1283 1289 (Pubitemid 32917122)
35. E.B. Gomez Garcia, J.C. Oosterwijk, and M. Timmermans A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history Breast Cancer Res 11 2009 R8
36. J.T. Rabban, E. Krasik, and L.M. Chen Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol Am J Surg Pathol 33 2009 1878 1885
37. D.W. Kindelberger, Y. Lee, and A. Miron Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2007 161 169 (Pubitemid 46175016)
38. K. Rhiem, D. Foth, and B. Wappenschmidt Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers Arch Gynecol Obstet 283 2011 623 627
39. I.M. Collins, S.M. Domchek, D.G. Huntsman, and G. Mitchell The tubal hypothesis of ovarian cancer: caution needed Lancet Oncol 12 2011 1089 1091
40. E. Leblanc, F. Narducci, and I. Farre Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development Gynecol Oncol 121 2011 472 476